Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure

Clinical trial NCT01954030 · TERMINATED

Trial details

NCT number: NCT01954030
Sponsor: Annick Desjardins
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma (WHO Grade III or IV)

Start date: 2013-10-01
Primary completion: 2015-07-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.